SecSonar.com

10x Genomics, Inc. (TXG)

10x Genomics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

10x Genomics, Inc. (TXG) is a Medical - Healthcare Information Services company based in US with a market capitalization of $3.6B. Revenue grew 5.3% year-over-year and the company generated $130.1M in free cash flow. This page tracks TXG's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1.31K employees · IPO Sep 12, 2019

Valuation

Valuation & price

$21.20 · as of May 17, 2026 · -45.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.52

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$39.01$25.24$11.47Jul 25Dec 25Jul 26Jul 7, 25$11.92Jul 9, 25$12.10Jul 11, 25$12.80Jul 15, 25$12.22Jul 17, 25$12.45Jul 21, 25$11.54Jul 23, 25$13.62Jul 25, 25$14.11Jul 29, 25$14.00Jul 31, 25$13.45Aug 4, 25$13.68Aug 6, 25$12.66Aug 11, 25$12.31Aug 13, 25$13.57Aug 15, 25$13.36Aug 19, 25$13.41Aug 21, 25$13.10Aug 25, 25$14.07Aug 27, 25$14.02Aug 29, 25$14.01Sep 3, 25$13.34Sep 5, 25$13.96Sep 9, 25$13.50Sep 11, 25$13.06Sep 16, 25$13.13Sep 18, 25$13.27Sep 22, 25$13.04Sep 24, 25$12.06Sep 26, 25$11.72Sep 30, 25$11.69Oct 2, 25$12.31Oct 6, 25$12.64Oct 8, 25$12.07Oct 10, 25$11.47Oct 14, 25$11.54Oct 16, 25$12.38Oct 21, 25$13.03Oct 23, 25$13.36Oct 27, 25$13.59Oct 29, 25$12.90Oct 31, 25$13.64Nov 4, 25$13.36Nov 6, 25$13.00Nov 10, 25$17.08Nov 12, 25$16.69Nov 14, 25$15.89Nov 18, 25$15.56Nov 20, 25$16.46Nov 25, 25$19.07Nov 28, 25$18.81Dec 2, 25$17.94Dec 4, 25$18.15Dec 8, 25$17.47Dec 10, 25$17.53Dec 12, 25$15.46Dec 16, 25$15.71Dec 18, 25$16.00Dec 22, 25$16.94Dec 24, 25$16.69Dec 29, 25$16.15Jan 2, 26$16.62Jan 6, 26$19.31Jan 8, 26$19.29Jan 12, 26$19.80Jan 14, 26$20.92Jan 16, 26$20.52Jan 21, 26$22.68Jan 23, 26$22.38Jan 27, 26$21.62Jan 29, 26$20.80Feb 2, 26$19.95Feb 4, 26$19.06Feb 9, 26$18.54Feb 11, 26$19.15Feb 13, 26$18.12Feb 18, 26$19.57Feb 20, 26$18.88Feb 24, 26$19.10Feb 26, 26$22.13Mar 2, 26$23.14Mar 4, 26$22.37Mar 6, 26$20.81Mar 10, 26$20.46Mar 12, 26$18.94Mar 17, 26$18.09Mar 19, 26$18.38Mar 23, 26$19.14Mar 25, 26$20.91Mar 27, 26$19.48Mar 31, 26$21.23Apr 2, 26$22.33Apr 7, 26$21.82Apr 9, 26$23.00Apr 13, 26$23.58Apr 15, 26$25.35Apr 17, 26$26.08Apr 22, 26$22.83Apr 24, 26$22.08Apr 28, 26$21.37Apr 30, 26$22.05May 4, 26$21.65May 6, 26$22.74May 8, 26$21.60May 12, 26$20.92May 14, 26$21.52May 18, 26$21.45May 20, 26$23.98May 22, 26$23.68May 28, 26$27.99Jun 1, 26$29.59Jun 3, 26$32.16Jun 5, 26$31.04Jun 9, 26$30.59Jun 11, 26$29.05Jun 15, 26$32.22Jun 17, 26$32.13Jun 22, 26$32.94Jun 24, 26$34.60Jun 26, 26$36.75Jul 2, 26$39.01
$11.3452-week range$39.05
Loading valuation history…

Fundamentals

Key fundamentals

$3.6B

Market cap

5.3%

Revenue growth (YoY)

69.0%

Gross margin

$130.1M

Free cash flow (USD)

-$365.7M

Net debt

Net cash position

3.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$71.1MFY 2018$146.3MFY 2019$245.9MFY 2020$298.8MFY 2021$490.5MFY 2022$516.4MFY 2023$618.7MFY 2024$610.8MFY 2025$642.8M
$71.1M$642.8M

Free cash flow by year

2017 → 2025

FY 2017$-14.5MFY 2018$-83.1MFY 2019$-8.1MFY 2020$-256.3MFY 2021$-122.7MFY 2022$-165.3MFY 2023$-64.7MFY 2024$-5.7MFY 2025$130.1M
-$14.5M$130.1M

Gross margin by year

2021 → 2025

FY 202184.9%FY 202276.7%FY 202366.2%FY 202467.9%FY 202569.0%
84.9%69.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

6

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $1.0M · 10b5-1 PlanSaxonov Serge · Director, Chief Executive Officer · $1MJun 24, 2026Filing
  • Insider sellInsider Sell $187K · 10b5-1 PlanSULIMAN SHEHNAAZ · Director · $186.8KJun 18, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 8, 2026Filing
  • Insider sellInsider Sell $369KTaich Adam · Chief Financial Officer · $369KMay 27, 2026Filing
  • Insider sellInsider Sell $283KHindson Benjamin J. · Director, See Remarks · $283.4KMay 27, 2026Filing
  • Insider sellInsider Sell $709K · 10b5-1 PlanSaxonov Serge · Director, Chief Executive Officer · $709.1KMay 27, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Insider sellInsider Sell $123K · 10b5-1 PlanSaxonov Serge · Director, Chief Executive Officer · $122.8KApr 16, 2026Filing

Questions

Frequently asked questions

What is 10x Genomics, Inc.'s market cap?

10x Genomics, Inc. (TXG) has a market capitalization of $3.6B.

What is TXG's P/E ratio?

A meaningful P/E ratio is not available for TXG — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TXG's price-to-book (P/B) ratio?

TXG trades at 4.52 times book value per share.

Are insiders buying TXG stock?

SEC Form 4 filings show no open-market insider buys at 10x Genomics, Inc. in the last 90 days (6 sells).

Same arena

Related companies in Medical - Healthcare Information Services

DOCS

Doximity, Inc.

$4B

HNGE

Hinge Health, Inc.

$4.4B

HTFL

Heartflow, Inc. Common Stock

$2.7B

PRVA

Privia Health Group, Inc.

$2.7B

PGNY

Progyny, Inc.

$2B

OMCL

Omnicell, Inc.

$2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.